Luis Enrique Almaguer-Mederos

Dr. Luis Enrique Almaguer-Mederos

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2018 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
LALuis Enrique Almaguer-Mederos
Luis Enrique Almaguer-Mederos
JMJ.M.L. Mesa
J.M.L. Mesa
YGY. González‐Zaldívar
Y. González‐Zaldívar
DAD. Almaguer‐Gotay
D. Almaguer‐Gotay
DCD. Cuello‐Almarales
D. Cuello‐Almarales
LVL. Velázquez‐Pérez
L. Velázquez‐Pérez

6 February 2021 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
LALuis Enrique Almaguer-Mederos
Luis Enrique Almaguer-Mederos
IPIlbedis Pérez‐Ávila
Ilbedis Pérez‐Ávila
RARaúl Aguilera‐Rodríguez
Raúl Aguilera‐Rodríguez
MVMaria Velázquez‐Garcés
Maria Velázquez‐Garcés
DADennis Almaguer‐Gotay
Dennis Almaguer‐Gotay
GAGeorg Auburger
Georg Auburger

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
ADAlmaguer-Gotay Dennis
Almaguer-Gotay Dennis
LALuis Enrique Almaguer-Mederos
Luis Enrique Almaguer-Mederos
RRRodríguez-Aguilera Raúl
Rodríguez-Aguilera Raúl
RLRoberto Rodriguez Labrada
Roberto Rodriguez Labrada
LVLuis Velazquez-Perez
Luis Velazquez-Perez
TRTorres-Vega Reydenis
Torres-Vega Reydenis
Background. Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease presenting with redox imbalance. However, the nature and implications of redox imbalance in SCA2 physiopathology have not been fully understood. Objective. The objective of this study is to assess the redox imbalance and its association with disease severity in SCA2 mutation carriers. Methods. A case‐control study was conducted involving molecularly confirmed SCA2 patients, presymptomatic individuals, and healthy controls. Several antioxidant parameters were assessed, including serum thiol concentration and the superoxide dismutase, catalase, and glutathione S‐transferase enzymatic activities. Also, several prooxidant parameters were evaluated, including thiobarbituric acid‐reactive species and protein carbonyl concentrations. Damage, protective, and OXY scores were computed. Clinical correlates were established. Results. Significant differences were found between comparison groups for redox markers, including protein carbonyl concentration (F = 3.30; p = 0.041), glutathione S‐transferase activity (F = 4.88; p = 0.009), and damage (F = 3.20; p = 0.045), protection (F = 12.75; p < 0.001), and OXY (F = 7.29; p = 0.001) scores. Protein carbonyl concentration was positively correlated with CAG repeat length (r = 0.27; p = 0.022), while both protein carbonyl concentration (r = −0.27; p = 0.018) and OXY score (r = −0.25; p = 0.013) were inversely correlated to the disease duration. Increasing levels of antioxidants and decreasing levels of prooxidant parameters were associated with clinical worsening. Conclusions. There is a disruption of redox balance in SCA2 mutation carriers which depends on the disease stage. Besides, redox changes associate with markers of disease severity, suggesting a link between disruption of redox balance and SCA2 physiopathology.

21 May 2020 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
LALuis Enrique Almaguer-Mederos
Luis Enrique Almaguer-Mederos
RARaúl Aguilera-Rodríguez
Raúl Aguilera-Rodríguez
DADennis Almaguer-Gotay
Dennis Almaguer-Gotay
KHKenia Hechavarría-Barzaga
Kenia Hechavarría-Barzaga
AÁAmarilis Álvarez-Sosa
Amarilis Álvarez-Sosa
ARAnnelié Rodríguez-Estupiñán
Annelié Rodríguez-Estupiñán

23 September 2025 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
LALuis Enrique Almaguer-Mederos
Luis Enrique Almaguer-Mederos
AKArvind Reddy Kandi
Arvind Reddy Kandi
NSNesli-Ece Sen
Nesli-Ece Sen
JCJúlia Canet-Pons
Júlia Canet-Pons
LBLuca-Malena Berger
Luca-Malena Berger
GAGeorg Auburger
Georg Auburger
Toxic polyglutamine (polyQ) expansions in ATXN2 trigger neurodegenerative processes, causing Spinocerebellar Ataxia type 2 (SCA2), and enhancing TDP-43-dependent pathology in Amyotrophic Lateral Sclerosis (ALS) / Fronto-Temporal Dementia (FTD). Primary disease events can be compensated transiently, delaying disease manifestation. To define potential therapy targets, here we studied how cells modify phosphoprotein signals, using preferentially affected nervous tissue from end-stage Atxn2-CAG100-KnockIn mice. The spinal cord phosphoproteome revealed massive hyperphosphorylations flanking the polyQ expansion in ATXN2 and for SQSTM1, and moderate hyperphosphorylations also for ALS proteins OPTN, UBQLN2, TNIP1 and TBK1-targeted TAX1BP1. Conversely, strong hypophosphorylations of WNK1, SPARCL1 and PSMD9 were found. Significant enrichments of SH3-containing proteins, autophagy / endocytosis factors, and actin modulators could be explained by N-terminal, polyQ-adjacent, proline-rich motifs (PRM) in ATXN2, suggesting that SCA2 pathogenesis is highly similar to Huntington's disease where neurotoxicity is mediated by abnormal polyQ-PRM-SH3 interactions. Validation of protein and mRNA levels were done in mouse spinal cord, and embryonic fibroblasts or patient fibroblasts after bafilomycin or arsenite treatment, observing polyQ-dependent OPTN deficiency and SQSTM1 induction impairment. Overall, this phosphoproteome profile identified and quantified the main cellular efforts in adapting autophagy pathways to the aggregation propensity of the ATXN2-N-term.

16 June 2017 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
LALuis Enrique Almaguer-Mederos
Luis Enrique Almaguer-Mederos
RARaúl Aguilera‐Rodríguez
Raúl Aguilera‐Rodríguez
DCDany Cuello‐Almarales
Dany Cuello‐Almarales
DADennis Almaguer‐Gotay
Dennis Almaguer‐Gotay
YGYanetza González‐Zaldívar
Yanetza González‐Zaldívar
LVLuis Velázquez‐Pérez
Luis Velázquez‐Pérez